CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Open-market sale Chief Scientific Officer sold 336 shares at $25.10 ($8,434)
- 4 Open-market sale Chief Business Officer sold 451 shares at $25.10 ($11,320)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 319 shares at $21.11 ($6,734)
- 4 Open-market sale Chief Technology Officer sold 447 shares at $21.11 ($9,436)
- 4 Open-market sale Chief Operating Officer sold 447 shares at $21.11 ($9,436)
- 4 Open-market sale President and CFO sold 376 shares at $21.11 ($7,937)
- 4 Open-market sale Chief Business Officer sold 447 shares at $21.11 ($9,436)
- 4 Open-market sale Chief Executive Officer sold 1,486 shares at $21.11 ($31,369)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Open-market sale Chief Business Officer sold 1,801 shares at $29.06 ($52,337)
- 4 Open-market sale Chief Operating Officer sold 1,801 shares at $29.06 ($52,337)
- 4 Open-market sale Chief Medical Officer sold 1,801 shares at $29.06 ($52,337)
- 4 Open-market sale Chief Technology Officer sold 1,801 shares at $29.06 ($52,337)
- 4 Open-market sale Chief Scientific Officer sold 1,817 shares at $29.06 ($52,802)
- 4 Open-market sale President and CFO sold 1,815 shares at $29.06 ($52,744)
- 4 Grant or award Director acquired 5,750 shares (grant or award)
Page 8 of 16 · 304 filings